How to kill Pseudomonas —emerging therapies for a challenging pathogen
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
How to kill
Pseudomonas
—emerging therapies for a challenging pathogen
Authors
Keywords
-
Journal
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-04-08
DOI
10.1111/nyas.14596
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Novel Group of Promiscuous Podophages Infecting Diverse Gammaproteobacteria from River Communities Exhibits Dynamic Intergenus Host Adaptation
- (2021) Daniel Cazares et al. mSystems
- Antimicrobial activity of POL7306 tested against clinical isolates of Gram-negative bacteria collected worldwide
- (2020) Helio S Sader et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Mechanism of Action of Surface Immobilized Antimicrobial Peptides Against Pseudomonas aeruginosa
- (2020) Muhammad Yasir et al. Frontiers in Microbiology
- Escape mutations circumvent a tradeoff between resistance to a beta-lactam and resistance to a beta-lactamase inhibitor
- (2020) Dor Russ et al. Nature Communications
- Hit Identification of New Potent PqsR Antagonists as Inhibitors of Quorum Sensing in Planktonic and Biofilm Grown Pseudomonas aeruginosa
- (2020) Fadi Soukarieh et al. Frontiers in Chemistry
- Pseudomonas aeruginosa is capable of natural transformation in biofilms
- (2020) Laura M. Nolan et al. MICROBIOLOGY-SGM
- Gallium(III)–Salophen as a Dual Inhibitor of Pseudomonas aeruginosa Heme Sensing and Iron Acquisition
- (2020) Garrick Centola et al. ACS Infectious Diseases
- Secondary Bacterial Infections in Patients With Viral Pneumonia
- (2020) Prasanth Manohar et al. Frontiers in Medicine
- Diverse enzymatic activities mediate antiviral immunity in prokaryotes
- (2020) Linyi Gao et al. SCIENCE
- Genome-Based Approach Delivers Vaccine Candidates Against Pseudomonas aeruginosa
- (2019) Irene Bianconi et al. Frontiers in Immunology
- Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection
- (2019) Johanna M. Sweere et al. SCIENCE
- Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli
- (2019) George G. Zhanel et al. DRUGS
- The Novel β-Lactam Enhancer Zidebactam Augments the In Vivo Pharmacodynamic Activity of Cefepime in a Neutropenic Mouse Lung Acinetobacter baumannii Infection Model
- (2019) S. S. Bhagwat et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Defining the core essential genome of Pseudomonas aeruginosa
- (2019) Bradley E. Poulsen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Thiostrepton hijacks pyoverdine receptors to inhibit growth of Pseudomonas aeruginosa
- (2019) Michael R.M. Ranieri et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nacubactam Enhances Meropenem Activity against Carbapenem-Resistant Klebsiella pneumoniae Producing KPC
- (2019) Melissa D. Barnes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identification of a potent inhibitor of type II secretion system from Pseudomonas aeruginosa
- (2019) Wieslaw Swietnicki et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections
- (2019) Juan P. Horcajada et al. CLINICAL MICROBIOLOGY REVIEWS
- Polymyxin B analog SPR741 potentiates antibiotics against Gram-negative bacteria and uniquely perturbs the outer membrane
- (2019) Shawn French et al. ACS Infectious Diseases
- WCK 5222 (Cefepime-Zidebactam) Pharmacodynamic Target Analysis against Metallo-β-Lactamase-Producing Enterobacteriaceae in the Neutropenic Mouse Pneumonia Model
- (2019) Alexander J. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Chimeric peptidomimetic antibiotics against Gram-negative bacteria
- (2019) Anatol Luther et al. NATURE
- Steering Phages to Combat Bacterial Pathogens
- (2019) James Gurney et al. TRENDS IN MICROBIOLOGY
- Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance
- (2019) Réka Spohn et al. Nature Communications
- Mimicking the human environment in mice reveals that inhibiting biotin biosynthesis is effective against antibiotic-resistant pathogens
- (2019) Lindsey A. Carfrae et al. Nature Microbiology
- LB4. Efficacy and Safety of Cefiderocol vs. High-Dose Meropenem in Patients with Nosocomial Pneumonia—Results of a Phase 3, Randomized, Multicenter, Double-Blind, Non-Inferiority Study
- (2019) Richard G Wunderink et al. Open Forum Infectious Diseases
- 674. Pre-Clinical and Phase I Safety Data for Anti-Pseudomonas aeruginosa Human Monoclonal Antibody AR-105
- (2019) Andreas Loos et al. Open Forum Infectious Diseases
- Long Term Compassionate Use of Cefiderocol to Treat Chronic Osteomyelitis Caused by XDR-Pseudomonas aeruginosa and ESBL-producing Klebsiella pneumoniae in a Pediatric Patient
- (2019) Zain I. Alamarat et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in Enterobacterales and Pseudomonas aeruginosa
- (2019) Jodie C. Hamrick et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Design of a Broad-Range Bacteriophage Cocktail That Reduces Pseudomonas aeruginosa Biofilms and Treats Acute Infections in Two Animal Models
- (2018) Francesca Forti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo Efficacy of Meropenem, with a novel non-β-lactam β-lactamase Inhibitor, Nacubactam, against Gram-negative Organisms Exhibiting Various Resistance Mechanisms in a Murine Complicated Urinary Tract Infection Model
- (2018) Marguerite L. Monogue et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial Infections
- (2018) Matt Shirley DRUGS
- KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa
- (2018) R. Jain et al. Journal of Cystic Fibrosis
- Pseudomonas aeruginosatranscriptome during human infection
- (2018) Daniel M. Cornforth et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systematic discovery of antiphage defense systems in the microbial pangenome
- (2018) Shany Doron et al. SCIENCE
- Synergy between conventional antibiotics and anti-biofilm peptides in a murine, sub-cutaneous abscess model caused by recalcitrant ESKAPE pathogens
- (2018) Daniel Pletzer et al. PLoS Pathogens
- Pore-forming activity of the Pseudomonas aeruginosa type III secretion system translocon alters the host epigenome
- (2018) Laurent Dortet et al. Nature Microbiology
- Identification of FDA-approved drugs as antivirulence agents targeting the pqs quorum sensing system of Pseudomonas aeruginosa
- (2018) Francesca D'Angelo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Assessment of the In Vivo Efficacy of WCK 5222 (Cefepime-Zidebactam) Against Carbapenem-Resistant Acinetobacter baumannii in the Neutropenic Murine Lung Infection Model
- (2018) Lindsay M. Avery et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanisms of biofilm stimulation by subinhibitory concentrations of antimicrobials
- (2018) Michael RM Ranieri et al. CURRENT OPINION IN MICROBIOLOGY
- Phage morons play important roles in controlling Pseudomonas aeruginosa phenotypes
- (2018) Yu-Fan Tsao et al. JOURNAL OF BACTERIOLOGY
- Model-based drug development in pulmonary delivery: Pharmacokinetic analysis of novel drug candidates for treatment of Pseudomonas aeruginosa lung infection
- (2018) Tomás Sou et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Single-Center Evaluation of the Pharmacokinetics of WCK 5222 (Cefepime-Zidebactam Combination) in Subjects with Renal Impairment
- (2018) Richard A. Preston et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
- (2018) Zheng Pang et al. BIOTECHNOLOGY ADVANCES
- Activity of nacubactam (RG6080/OP0595) combinations against MBL-producing Enterobacteriaceae
- (2018) Shazad Mushtaq et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Negative feedback increases information transmission, enabling bacteria to discriminate sublethal antibiotic concentrations
- (2018) Raul Ruiz et al. Science Advances
- Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria
- (2017) Pooi Yin Chung et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
- (2017) Seth W. Dickey et al. NATURE REVIEWS DRUG DISCOVERY
- Novel “Superspreader” Bacteriophages Promote Horizontal Gene Transfer by Transformation
- (2017) Eric C. Keen et al. mBio
- An engineered bispecific DNA-encoded IgG antibody protects against Pseudomonas aeruginosa in a pneumonia challenge model
- (2017) Ami Patel et al. Nature Communications
- Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance
- (2017) Jonathan M. Stokes et al. Nature Microbiology
- Pseudomonas aeruginosa defends against phages through type IV pilus glycosylation
- (2017) Hanjeong Harvey et al. Nature Microbiology
- Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?
- (2016) Alexandre P. Zavascki et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenem-Resistant Pseudomonas aeruginosa Bacteremia: Risk Factors for Mortality and Microbiologic Treatment Failure
- (2016) Deanna J. Buehrle et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Considerations and caveats in anti-virulence drug development
- (2016) Damien Maura et al. CURRENT OPINION IN MICROBIOLOGY
- Parasite diversity drives rapid host dynamics and evolution of resistance in a bacteria-phage system
- (2016) Alex Betts et al. EVOLUTION
- Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003–2015)
- (2016) Paulina Kosikowska et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Antibiotic combination therapy can select for broad-spectrum multidrug resistance in Pseudomonas aeruginosa
- (2016) Martin Vestergaard et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antimicrobial activity of antisense peptide–peptide nucleic acid conjugates against non-typeable Haemophilus influenzae in planktonic and biofilm forms
- (2016) Taketo Otsuka et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- High Throughput Combinatorial Formatting of PcrV Nanobodies for Efficient Potency Improvement
- (2016) Evelyn De Tavernier et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
- (2016) Yi-Yun Liu et al. LANCET INFECTIOUS DISEASES
- Synergistic Antipseudomonal Effects of Synthetic Peptide AMP38 and Carbapenems
- (2016) Héctor Rudilla et al. MOLECULES
- Targeting the Type Three Secretion System in Pseudomonas aeruginosa
- (2016) Ahalieyah Anantharajah et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The CpxQ sRNA Negatively Regulates Skp To Prevent Mistargeting of β-Barrel Outer Membrane Proteins into the Cytoplasmic Membrane
- (2016) Marcin Grabowicz et al. mBio
- Tripartite assembly of RND multidrug efflux pumps
- (2016) Laetitia Daury et al. Nature Communications
- Antibacterial Antifolates: From Development through Resistance to the Next Generation
- (2016) Alexavier Estrada et al. Cold Spring Harbor Perspectives in Medicine
- Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa
- (2016) Benjamin K. Chan et al. Scientific Reports
- Dual-seq transcriptomics reveals the battle for iron during Pseudomonas aeruginosa acute murine pneumonia
- (2016) F. Heath Damron et al. Scientific Reports
- Extracellular DNA Acidifies Biofilms and Induces Aminoglycoside Resistance in Pseudomonas aeruginosa
- (2015) Mike Wilton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins
- (2015) M. Berrazeg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mutant Alleles oflptDIncrease the Permeability of Pseudomonas aeruginosa and Define Determinants of Intrinsic Resistance to Antibiotics
- (2015) Carl J. Balibar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and structure–activity relationships of novel phenoxyacetamide inhibitors of the Pseudomonas aeruginosa type III secretion system (T3SS)
- (2015) John D. Williams et al. BIOORGANIC & MEDICINAL CHEMISTRY
- D-Enantiomeric Peptides that Eradicate Wild-Type and Multidrug-Resistant Biofilms and Protect against Lethal Pseudomonas aeruginosa Infections
- (2015) César de la Fuente-Núñez et al. CHEMISTRY & BIOLOGY
- Azithromycin and ciprofloxacin: A possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections
- (2015) Hina Saini et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Association of overexpression of efflux pump genes with antibiotic resistance in Pseudomonas aeruginosa strains clinically isolated from urinary tract infection patients
- (2015) Katsumi Shigemura et al. JOURNAL OF ANTIBIOTICS
- Full characterization of the integrative and conjugative element carrying the metallo-β-lactamaseblaSPM-1and bicyclomycinbcr1resistance genes found in the pandemicPseudomonas aeruginosaclone SP/ST277 : Figure 1.
- (2015) Erica L. Fonseca et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pre-adapting parasitic phages to a pathogen leads to increased pathogen clearance and lowered resistance evolution withPseudomonas aeruginosacystic fibrosis bacterial isolates
- (2015) V-P. Friman et al. JOURNAL OF EVOLUTIONARY BIOLOGY
- Essential genome ofPseudomonas aeruginosain cystic fibrosis sputum
- (2015) Keith H. Turner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multidrug evolutionary strategies to reverse antibiotic resistance
- (2015) M. Baym et al. SCIENCE
- Phylogenetic Distribution of CRISPR-Cas Systems in Antibiotic-Resistant Pseudomonas aeruginosa
- (2015) Alex van Belkum et al. mBio
- Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa
- (2015) Jürg Dreier et al. Frontiers in Microbiology
- 6-Gingerol reduces Pseudomonas aeruginosa biofilm formation and virulence via quorum sensing inhibition
- (2015) Han-Shin Kim et al. Scientific Reports
- A bioinspired peptide scaffold with high antibiotic activity and low in vivo toxicity
- (2015) Francesc Rabanal et al. Scientific Reports
- Combination of hypothiocyanite and lactoferrin (ALX-109) enhances the ability of tobramycin and aztreonam to eliminate Pseudomonas aeruginosa biofilms growing on cystic fibrosis airway epithelial cells
- (2014) S. Moreau-Marquis et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Targeting virulence: can we make evolution-proof drugs?
- (2014) Richard C. Allen et al. NATURE REVIEWS MICROBIOLOGY
- Microbiological effects of sublethal levels of antibiotics
- (2014) Dan I. Andersson et al. NATURE REVIEWS MICROBIOLOGY
- A multifunctional bispecific antibody protects against Pseudomonas aeruginosa
- (2014) A. DiGiandomenico et al. Science Translational Medicine
- Broad-Spectrum Anti-biofilm Peptide That Targets a Cellular Stress Response
- (2014) César de la Fuente-Núñez et al. PLoS Pathogens
- Identification of Anti-virulence Compounds That Disrupt Quorum-Sensing Regulated Acute and Persistent Pathogenicity
- (2014) Melissa Starkey et al. PLoS Pathogens
- High-Throughput Screening Using the Differential Radial Capillary Action of Ligand Assay Identifies Ebselen As an Inhibitor of Diguanylate Cyclases
- (2013) Ori J. Lieberman et al. ACS Chemical Biology
- Siderophore conjugates
- (2013) Malcolm G. P. Page Annals of the New York Academy of Sciences
- Structure and Function of the Type III Secretion System of Pseudomonas aeruginosa
- (2013) Marlies Galle et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Sequestration and Scavenging of Iron in Infection
- (2013) Nermi L. Parrow et al. INFECTION AND IMMUNITY
- Combination antibiotic therapy versus monotherapy for Pseudomonas aeruginosa bacteraemia: A meta-analysis of retrospective and prospective studies
- (2013) Yangmin Hu et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study
- (2013) Mikhail V Edelstein et al. LANCET INFECTIOUS DISEASES
- Cyclic di-GMP: the First 25 Years of a Universal Bacterial Second Messenger
- (2013) U. Romling et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation
- (2013) C. T. O'Loughlin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of aPseudomonas aeruginosahybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers
- (2013) Kerstin Westritschnig et al. Human Vaccines & Immunotherapeutics
- Pseudomonas aeruginosaTwitching Motility: Type IV Pili in Action
- (2012) Lori L. Burrows Annual Review of Microbiology
- Chemical Inhibitors of the Type Three Secretion System: Disarming Bacterial Pathogens
- (2012) Miles C. Duncan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New Life for an Old Drug: the Anthelmintic Drug Niclosamide Inhibits Pseudomonas aeruginosa Quorum Sensing
- (2012) F. Imperi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
- (2012) P. D. Tamma et al. CLINICAL MICROBIOLOGY REVIEWS
- Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa
- (2012) Bruno François et al. CRITICAL CARE MEDICINE
- Targeting RNA Polymerase Primary σ70 as a Therapeutic Strategy against Methicillin-Resistant Staphylococcus aureus by Antisense Peptide Nucleic Acid
- (2012) Hui Bai et al. PLoS One
- Non-Traditional Antibacterial Screening Approaches for the Identification of Novel Inhibitors of the Glyoxylate Shunt in Gram-Negative Pathogens
- (2012) Kelly C. Fahnoe et al. PLoS One
- Pseudomonas aeruginosa Keratitis in Mice: Effects of Topical Bacteriophage KPP12 Administration
- (2012) Ken Fukuda et al. PLoS One
- Identification of EPS-degrading activity within the tail spikes of the novel Pseudomonas putida phage AF
- (2012) Anneleen Cornelissen et al. VIROLOGY
- Small molecules aimed at type III secretion systems to inhibit bacterial virulence
- (2012) Lun K. Tsou et al. MedChemComm
- A lipocentric view of peptide-induced pores
- (2011) Gustavo Fuertes et al. EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
- Bacteriophages and diffusion of genes encoding antimicrobial resistance in cystic fibrosis sputum microbiota
- (2011) L. Fancello et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antibacterial efficacy of lytic Pseudomonas bacteriophage in normal and neutropenic mice models
- (2011) Birendra R. Tiwari et al. JOURNAL OF MICROBIOLOGY
- Pseudomonas aeruginosa: all roads lead to resistance
- (2011) Elena B.M. Breidenstein et al. TRENDS IN MICROBIOLOGY
- Selection of Resistant Bacteria at Very Low Antibiotic Concentrations
- (2011) Erik Gullberg et al. PLoS Pathogens
- Discovery and Characterization of Inhibitors of Pseudomonas aeruginosa Type III Secretion
- (2010) D. Aiello et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- How Pseudomonas aeruginosa adapts to various environments: a metabolomic approach
- (2010) Eliane Frimmersdorf et al. ENVIRONMENTAL MICROBIOLOGY
- A Differential Drug Screen for Compounds That Select Against Antibiotic Resistance
- (2010) Remy Chait et al. PLoS One
- Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa
- (2010) N. Srinivas et al. SCIENCE
- Triclosan Resistance of Pseudomonas aeruginosa PAO1 Is Due to FabV, a Triclosan-Resistant Enoyl-Acyl Carrier Protein Reductase
- (2009) L. Zhu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms
- (2009) P. D. Lister et al. CLINICAL MICROBIOLOGY REVIEWS
- A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistantPseudomonas aeruginosa; a preliminary report of efficacy
- (2009) A. Wright et al. CLINICAL OTOLARYNGOLOGY
- Adaptive prediction of environmental changes by microorganisms
- (2009) Amir Mitchell et al. NATURE
- Drug interactions and the evolution of antibiotic resistance
- (2009) Pamela J. Yeh et al. NATURE REVIEWS MICROBIOLOGY
- Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials
- (2009) Maya Merabishvili et al. PLoS One
- Molecular basis of pyoverdine siderophore recycling in Pseudomonas aeruginosa
- (2009) F. Imperi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy
- (2009) T. K. Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Are essential genes really essential?
- (2009) Michael A. D’Elia et al. TRENDS IN MICROBIOLOGY
- Effects of Antibiotics on Quorum Sensing in Pseudomonas aeruginosa
- (2008) M. E. Skindersoe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Occurrence and mechanisms of amikacin resistance and its association with β-lactamases in Pseudomonas aeruginosa: a Korean nationwide study
- (2008) Ja-Young Kim et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Capsule polysaccharide is a bacterial decoy for antimicrobial peptides
- (2008) E. Llobet et al. MICROBIOLOGY-SGM
- Drug interactions modulate the potential for evolution of resistance
- (2008) J.-B. Michel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dynamics of Pseudomonas aeruginosa genome evolution
- (2008) K. Mathee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search